Search research articles
Contact Us
Filters
Showing results (351-360 of 385) with videos related to
Page
of 39
Sort By:
The Lancet. Oncology
|
January 30, 2008
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
Michael Pfreundschuh, Joerg Schubert, Marita Ziepert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2017
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
Annette M Staiger, Marita Ziepert, Heike Horn, et al.
Leukemia
|
September 19, 2019
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL
Annette M Staiger, Michael Altenbuchinger, Marita Ziepert, et al.
Hemasphere
|
February 26, 2026
Autologous stem cell transplantation in major T-cell lymphoma entities: An analysis by the EBMT Lymphoma Working Party
Evgenii Shumilov, Maud Ngoya, Philipp Berning, et al.
Leukemia & Lymphoma
|
August 26, 2017
Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC
Ulrike Paul, Julia Richter, Christiane Stuhlmann-Laiesz, et al.
Blood
|
March 25, 2009
Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation
José L Díez-Martín, Pascual Balsalobre, Alessandro Re, et al.
The Lancet. Haematology
|
July 2, 2026
Autologous and allogeneic haematopoietic cell transplantation in adult patients with Hodgkin lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee and Lymphoma Working Party
Ali Bazarbachi, Ranjana Advani, Sairah Ahmed, et al.
BMC Pregnancy and Childbirth
|
May 7, 2015
QF2011: a protocol to study the effects of the Queensland flood on pregnant women, their pregnancies, and their children's early development
Suzanne King, Sue Kildea, Marie-Paule Austin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2016
Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma
Michael Crump, Sirpa Leppä, Luis Fayad, et al.
Blood Advances
|
December 3, 2021
Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics
Mehdi Hamadani, Maud Ngoya, Anna Sureda, et al.
Page
of 39
Search research articles
Search
Showing results (351-360 of 385) with videos related to
Sort By:
Page
of 39
The Lancet. Oncology
|
January 30, 2008
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
Michael Pfreundschuh, Joerg Schubert, Marita Ziepert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2017
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
Annette M Staiger, Marita Ziepert, Heike Horn, et al.
Leukemia
|
September 19, 2019
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL
Annette M Staiger, Michael Altenbuchinger, Marita Ziepert, et al.
Hemasphere
|
February 26, 2026
Autologous stem cell transplantation in major T-cell lymphoma entities: An analysis by the EBMT Lymphoma Working Party
Evgenii Shumilov, Maud Ngoya, Philipp Berning, et al.
Leukemia & Lymphoma
|
August 26, 2017
Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC
Ulrike Paul, Julia Richter, Christiane Stuhlmann-Laiesz, et al.
Blood
|
March 25, 2009
Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation
José L Díez-Martín, Pascual Balsalobre, Alessandro Re, et al.
The Lancet. Haematology
|
July 2, 2026
Autologous and allogeneic haematopoietic cell transplantation in adult patients with Hodgkin lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee and Lymphoma Working Party
Ali Bazarbachi, Ranjana Advani, Sairah Ahmed, et al.
BMC Pregnancy and Childbirth
|
May 7, 2015
QF2011: a protocol to study the effects of the Queensland flood on pregnant women, their pregnancies, and their children's early development
Suzanne King, Sue Kildea, Marie-Paule Austin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2016
Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma
Michael Crump, Sirpa Leppä, Luis Fayad, et al.
Blood Advances
|
December 3, 2021
Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics
Mehdi Hamadani, Maud Ngoya, Anna Sureda, et al.
Page
of 39